According to Turnstone Biologics's latest financial reports the company's current EPS (TTM) is -1,74ย โฌ. In 2024 the company made an earnings per share (EPS) of -2,61ย โฌ a decrease over its 2023 EPS that were of -2,30ย โฌ.